TY  - JOUR 
AU  - Hidalgo Tenorio, Carmen
AU  - Pasquau, Juan
AU  - Vinuesa, David
AU  - Ferra, Sergio
AU  - Terrón, Alberto
AU  - Payeras, Albertp
AU  - SanJoaquin, Isabel
AU  - Martinez, Onofre Juan
AU  - López Ruz, Miguel Ángel
AU  - Omar, Mohamed
AU  - De la Torre Lima, Javier
AU  - López Lirola, Ana
AU  - Palomares, Jesús
AU  - Blanco, José Ramón
AU  - Montero, Marta
AU  - García Vallecillos, Coral
PY  - 2022
UR  - https://hdl.handle.net/10481/90899
AB  - Brief: Real-world data in naïve HIV-1 patients demonstrate that dolutegravir plus lamivudine in a multiple tablet regimen is effective, safe, and satisfactory; it causes moderately increasing weight and abdominal circumference and is administrable on...
LA  - eng
TI  - DOLAVI Real-Life Study of Dolutegravir Plus Lamivudine in Naive HIV-1 Patients (48 Weeks)
DO  - 10.3390/v14030524
ER  -